| Open Document File Size: 381,09 KBShare Result on Facebook
City Scottsdale / / Company Medicis Aesthetics Holdings Inc. / U.S. Medicis / Diary AE / Medicis Aesthetics Inc. / / Country Norway / United States / Iceland / Liechtenstein / / Currency pence / / Event FDA Phase / / IndustryTerm polysaccharide chain / chemical peeling procedures / pharmaceuticals / injection site / molecular network / chemical peeling / chemical stabilizing process / authorized distributor / / MedicalCondition active inflammatory process / blisters / facial contour deformities / scar / keloids / specific diseases / allergies / inflammatory reaction / post-inflammatory hyperpigmentation / Inflammatory papules / hyperpigmentation / scars / hives / cysts / soft tissue infection / anaphylaxis / herpes / cold sores / moderate inflammatory symptoms / Itching / Localized superficial necrosis / pain / numbness / blister / acne vulgaris / cold sore / Delayed onset inflammatory papules / injury / severe allergies / infection / Keloid / collagen vascular disease / disorders / / MedicalTreatment laser treatment / epilation / face lift / retreatment / immunosuppressive therapy / rhytidectomy / RESTYLANE / surgery / / Organization FDA / European Union / / / Position evaluator / physician / pilot U.S. study / GENERAL INFORMATION Device Generic Name / / Product Restylane / Restylane injections / Restylane injection / Panel Track Supplement / RESTYLANE® Injectable Gel Applicant / United States / / ProvinceOrState Arizona / / Technology laser / /
SocialTag |
Restylane Summary of the Safety and Effectiveness of Data (Clean)